GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 21, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	422,973	487,432	329,173	224,319	281,714	244,012
Market Cap Growth	-8.53%	48.08%	46.74%	-20.37%	15.45%	15.67%
Enterprise Value	402,721	466,472	313,334	211,499	270,099	237,483
Last Close Price	2497.90	2843.28	1889.18	1257.08	1489.75	1263.15
PE Ratio	44.28	52.55	55.80	36.73	16.62	68.13
PS Ratio	11.40	13.00	9.53	6.90	8.59	8.34
PB Ratio	24.77	24.98	18.52	12.88	10.58	16.51
P/TBV Ratio	24.89	25.15	18.77	13.14	10.72	17.01
P/FCF Ratio	58.82	38.48	59.76	50.96	36.30	45.72
P/OCF Ratio	56.90	37.79	56.56	46.33	34.75	42.22
EV/Sales Ratio	10.86	12.44	9.07	6.50	8.24	8.12
EV/EBITDA Ratio	33.40	40.47	35.58	26.83	36.36	41.42
EV/EBIT Ratio	35.04	41.86	37.35	28.26	38.65	45.71
EV/FCF Ratio	56.00	36.82	56.89	48.05	34.80	44.50
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.03	0.01	0.02	0.02	0.03	0.06
Debt / FCF Ratio	0.05	0.01	0.03	0.04	0.03	0.07
Asset Turnover	1.00	0.98	1.00	0.82	0.85	0.94
Inventory Turnover	2.62	2.81	2.75	2.62	2.55	2.49
Quick Ratio	1.43	1.50	1.45	1.50	1.83	1.02
Current Ratio	1.78	1.79	1.84	1.88	2.18	1.63
Return on Equity (ROE)	56.52%	49.75%	33.53%	27.59%	18.39%	17.42%
Return on Assets (ROA)	19.39%	18.17%	15.24%	11.75%	11.28%	10.39%
Return on Capital (ROIC)	41.88%	37.07%	29.52%	21.07%	20.82%	19.24%
Return on Capital Employed (ROCE)	57.70%	50.60%	41.30%	37.40%	23.80%	29.50%
Earnings Yield	2.26%	1.90%	1.79%	2.72%	6.02%	1.47%
FCF Yield	1.70%	2.60%	1.67%	1.96%	2.76%	2.19%
Dividend Yield	2.15%	1.48%	1.69%	2.55%	2.01%	2.38%
Payout Ratio	96.18%	80.79%	91.80%	249.80%	29.89%	189.04%
Total Shareholder Return	2.15%	1.48%	1.69%	2.55%	2.01%	2.38%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.